Handa Pharmaceuticals
TWD107.50
7
+TWD9.50+9.69% Friday 04:28
Statistics
Day High
107.5
Day Low
107.5
52W High
154
52W Low
64.1
Volume
2,709
Avg. Volume
-
Mkt Cap
18.27B
P/E Ratio
-
Dividend Yield
1.93%
Dividend
2.07
Upcoming
Dividends
1.93%Dividend Yield
Jul 26
TWD2.07
Jul 25
TWD1.51
May 24
TWD1.00
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
37.63%
Earnings
13NovExpected
Q1 2026
Q2 2026
Next
0.23
1
1.77
2.54
Expected EPS
2.538255493305
Actual EPS
N/A
Financials
43.36%Profit Margin
Profitable1.73BRevenue
749.77MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 6620.TWO. It's not an investment recommendation.
Yuanta/P-shares Taiwan Top 50
5
0050.TW
Taichung Commercial Bank
5
2812.TW
Foresee Pharmaceuticals
5
6576.TWO
Richmond International Travel & Tours
5
2743.TWO
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Handa Pharmaceuticals, Inc. operates as a specialized drug company, concentrating its efforts on creating and advancing new medications for diverse health issues across both the United States and China. The firm currently offers Quetiapine XR, a treatment for Schizophrenia, as well as Dexlansoprazole DR capsules. Beyond its existing portfolio, Handa is actively cultivating a robust pipeline of therapies. This includes their cutting-edge ONCORE drug delivery platform, engineered to boost patient adherence and improve the safety of tyrosine kinase inhibitor oncology drugs. Other significant projects encompass a 505(b)(2)NDA therapeutic agent, Tascenso ODT for managing multiple sclerosis, and the oncology candidates HND-033 and HND-027. Furthermore, the company's development initiatives feature HND-004, designed for diabetic patients; HND-032, intended to aid in smoking cessation; and HND-026, a gastrointestinal medication. Founded in 2014, Handa Pharmaceuticals, Inc. has its main corporate headquarters situated in Tainan City, Taiwan.
Show more...
CEO
Fang-Yu Liu
Employees
15
Country
Taiwan
ISIN
TW0006620008
Listings
0 Comments
Share your thoughts
FAQ
What is Handa Pharmaceuticals stock price today?▼
The current price of 6620.TWO is TWD107.50 TWD — it has increased by +9.69% in the past 24 hours. Watch Handa Pharmaceuticals stock price performance more closely on the chart.
What is Handa Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Handa Pharmaceuticals stocks are traded under the ticker 6620.TWO.
Is Handa Pharmaceuticals stock price growing?▼
6620.TWO stock has risen by +27.22% compared to the previous week, the month change is a +25.15% rise, over the last year Handa Pharmaceuticals has showed a +30.78% increase.
What is Handa Pharmaceuticals market cap?▼
Today Handa Pharmaceuticals has the market capitalization of 18.27B
When is the next Handa Pharmaceuticals earnings date?▼
Handa Pharmaceuticals is going to release the next earnings report on November 13, 2026.
What were Handa Pharmaceuticals earnings last quarter?▼
6620.TWO earnings for the last quarter are 0.23 TWD per share, whereas the estimation was 0.29 TWD resulting in a -21.05% surprise. The estimated earnings for the next quarter are N/A TWD per share.
What is Handa Pharmaceuticals revenue for the last year?▼
Handa Pharmaceuticals revenue for the last year amounts to 1.73B TWD.
What is Handa Pharmaceuticals net income for the last year?▼
6620.TWO net income for the last year is 749.77M TWD.
Does Handa Pharmaceuticals pay dividends?▼
Yes, 6620.TWO dividends are paid annual. The last dividend per share was 2.07 TWD. As of today, Dividend Yield (FWD)% is 1.93%.
How many employees does Handa Pharmaceuticals have?▼
As of September 06, 2026, the company has 15 employees.
In which sector is Handa Pharmaceuticals located?▼
Handa Pharmaceuticals operates in the Health & Wellness sector.
When did Handa Pharmaceuticals complete a stock split?▼
Handa Pharmaceuticals has not had any recent stock splits.
Where is Handa Pharmaceuticals headquartered?▼
Handa Pharmaceuticals is headquartered in Tainan City, Taiwan.